» Articles » PMID: 26191246

CCAT1 Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion

Overview
Specialty Pathology
Date 2015 Jul 21
PMID 26191246
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that CCAT1 is involved in the development of malignancies including colon cancer and gastric cancer. However, the role of CCAT1 in HCC still remains unknown. Real-time PCR was performed to test the relative expression of CCAT1 in HCC tissues and cell lines. We performed Chi-Square Analysis to study the correlation between clinical characteristics and CCAT1 expression. Based on the correlation, cell proliferation assay, cell invasion assay, wound healing assay and cell apoptosis assay were conducted in two HCC cell lines to examine the regulatory effect of CCAT1 on the HCC cells. The results indicated that the expression of CCAT1 was significantly increased in HCC tissues and cells compared with controls. We also found that the abnormally expressed CCAT1 could promote cell proliferation, migration and invasion. Taken together, our findings demonstrated that the aberrant expression of CCAT1 promotes hepatocellular carcinoma in vitro.

Citing Articles

Role of long non-coding RNAs in cholangiocarcinoma: A systematic review and meta-analysis.

Shobeiri P, Bahri R, Khadembashiri M, Khadembashiri M, Maleki S, Eslami M Cancer Rep (Hoboken). 2024; 7(3):e2029.

PMID: 38517409 PMC: 10959185. DOI: 10.1002/cnr2.2029.


The Role of EMT-Related lncRNAs in Ovarian Cancer.

Lampropoulou D, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G Int J Mol Sci. 2023; 24(12).

PMID: 37373222 PMC: 10298523. DOI: 10.3390/ijms241210079.


Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Lin X, Xiang X, Feng B, Zhou H, Wang T, Chu X Front Oncol. 2021; 11:670838.

PMID: 34249710 PMC: 8267409. DOI: 10.3389/fonc.2021.670838.


Recent Advances of MicroRNAs, Long Non-coding RNAs, and Circular RNAs in Preeclampsia.

Chen A, Yu R, Jiang S, Xia Y, Chen Y Front Physiol. 2021; 12:659638.

PMID: 33995125 PMC: 8121253. DOI: 10.3389/fphys.2021.659638.


Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.

Pu J, Wu X, Wu Y, Shao Z, Luo C, Tang Q Aging (Albany NY). 2021; 13(8):12207-12223.

PMID: 33952719 PMC: 8109057. DOI: 10.18632/aging.103797.


References
1.
Dhar D, Seki E, Karin M . NCOA5, IL-6, type 2 diabetes, and HCC: The deadly quartet. Cell Metab. 2014; 19(1):6-7. PMC: 3947913. DOI: 10.1016/j.cmet.2013.12.010. View

2.
Colombo M, Iavarone M . Role of antiviral treatment for HCC prevention. Best Pract Res Clin Gastroenterol. 2014; 28(5):771-81. DOI: 10.1016/j.bpg.2014.07.017. View

3.
Di Martino M, Di Miscio R, De Filippis G, Lombardo C, Saba L, Geiger D . Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging. Abdom Imaging. 2013; 38(6):1254-62. DOI: 10.1007/s00261-013-0009-5. View

4.
Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q . Regulation of lncRNA expression. Cell Mol Biol Lett. 2014; 19(4):561-75. PMC: 6275606. DOI: 10.2478/s11658-014-0212-6. View

5.
Chavez M, Danniel J, Miick R, Jarrar D, Khanmoradi K, Ortiz J . Bone Metastases From HCC. JAMA Surg. 2013; 148(2):203-4. DOI: 10.1001/jamasurgery.2013.417b. View